CollPlant Biotechnologies Ltd — Form SCHEDULE 13D/A
Filed August 21, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Five entities controlled by Lillian S. Loewenbaum and George Walter Loewenbaum (three trusts, one partnership, plus two individuals) filed a joint Schedule 13D/A on August 21, 2026, regarding ordinary shares and warrants of CollPlant. The filing establishes a joint filing agreement for coordinated disclosure of their shareholdings but does not specify current ownership percentages, share counts, or acquisition details.
Why this rating
Joint filing agreement is administrative procedural requirement. No new ownership data, transaction value, or business impact disclosed; family coordination for reporting compliance only.
See more from August 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.